Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 73

    1.

    Significance of surgical treatment of liver metastases from gastric cancer.

    Miki Y, Fujitani K, Hirao M, Kurokawa Y, Mano M, Tsujie M, Miyamoto A, Nakamori S, Tsujinaka T.

    Anticancer Res. 2012 Feb;32(2):665-70.

    PMID:
    22287760
    [PubMed - indexed for MEDLINE]
    2.

    C-reactive protein is a potential prognostic factor for metastatic gastric cancer.

    Shimura T, Kitagawa M, Yamada T, Ebi M, Mizoshita T, Tanida S, Kataoka H, Kamiya T, Joh T.

    Anticancer Res. 2012 Feb;32(2):491-6.

    PMID:
    22287736
    [PubMed - indexed for MEDLINE]
    3.

    Oncogenic MST1R activity in pancreatic and gastric cancer represents a valid target of HSP90 inhibitors.

    Moser C, Lang SA, Hackl C, Zhang H, Lundgren K, Hong V, McKenzie A, Weber B, Park JS, Schlitt HJ, Geissler EK, Jung YD, Stoeltzing O.

    Anticancer Res. 2012 Feb;32(2):427-37.

    PMID:
    22287729
    [PubMed - indexed for MEDLINE]
    4.

    Trastuzumab has opposing effects on SN-38-induced double-strand breaks and cytotoxicity in HER2-positive gastric cancer cells depending on administration sequence.

    Yamade M, Sugimoto M, Nishino M, Uotani T, Sahara S, Iwaizumi M, Yamada T, Osawa S, Sugimoto K, Miyajima H, Furuta T.

    Anticancer Res. 2012 Jan;32(1):105-14.

    PMID:
    22213294
    [PubMed - indexed for MEDLINE]
    5.

    Weekly paclitaxel in combination with doxifluridine for peritoneally disseminated gastric cancer with malignant ascites.

    Takeyoshi I, Makita F, Iwazaki S, Ishikawa H, Kakinuma S, Sato Y, Ohya T, Nakagami K, Tomizawa N, Izumi M, Kobayashi I, Tanahashi Y, Kobayashi J, Kamoshita N, Kawate S, Sunose Y, Sakamoto I, Yoshinari D, Yamada T, Okabe T.

    Anticancer Res. 2011 Dec;31(12):4625-30.

    PMID:
    22199340
    [PubMed - indexed for MEDLINE]
    6.

    Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer. A multicenter phase II trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT).

    Wöll E, Greil R, Eisterer W, Bechter O, Fridrik MA, Grünberger B, Zabernigg A, Mayrbäurl B, Russ G, Dlaska M, Obrist P, Thaler J.

    Anticancer Res. 2011 Dec;31(12):4439-43.

    PMID:
    22199312
    [PubMed - indexed for MEDLINE]
    7.

    Targeting AKT protein kinase in gastric cancer.

    Almhanna K, Strosberg J, Malafa M.

    Anticancer Res. 2011 Dec;31(12):4387-92. Review.

    PMID:
    22199303
    [PubMed - indexed for MEDLINE]
    8.

    Genome-wide identification of chemosensitive single nucleotide polymorphism markers in gastric cancer.

    Ha YJ, Yoon SN, Jeon YJ, Cho DH, Roh SA, Kim BS, Kim HJ, Kim SY, Kim YS, Kim JC.

    Anticancer Res. 2011 Dec;31(12):4329-38.

    PMID:
    22199298
    [PubMed - indexed for MEDLINE]
    9.

    Detection of TFPI2 methylation in the serum of gastric cancer patients.

    Hibi K, Goto T, Shirahata A, Saito M, Kigawa G, Nemoto H, Sanada Y.

    Anticancer Res. 2011 Nov;31(11):3835-8.

    PMID:
    22110206
    [PubMed - indexed for MEDLINE]
    10.

    Antitumour activity of S-1 in combination with cetuximab on human gastric cancer cell lines in vivo.

    Kobunai T, Watanabe T, Fukusato T.

    Anticancer Res. 2011 Nov;31(11):3691-6.

    PMID:
    22110188
    [PubMed - indexed for MEDLINE]
    11.

    Identification of the distinctive type i/XhoI+ strain of Epstein-Barr virus in gastric carcinoma in Peru.

    Ordonez P, Koriyama C, Ding S, Yoshiwara E, Corvalan AH, Takano J, Chirinos JL, Watanabe J, Miyagui J, Hidalgo H, Chacon P, Linares V, Eizuru Y, Akiba S.

    Anticancer Res. 2011 Oct;31(10):3607-13.

    PMID:
    21965785
    [PubMed - indexed for MEDLINE]
    12.

    The role of chemotherapy in metastatic gastric cancer.

    Pasini F, Fraccon AP, DE Manzoni G.

    Anticancer Res. 2011 Oct;31(10):3543-54. Review.

    PMID:
    21965776
    [PubMed - indexed for MEDLINE]
    13.

    Down-regulation of EGFL8: a novel biomarker for advanced gastric cancer.

    Wu F, Shirahata A, Sakuraba K, Kitamura Y, Goto T, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y, Hibi K.

    Anticancer Res. 2011 Oct;31(10):3377-80.

    PMID:
    21965749
    [PubMed - indexed for MEDLINE]
    14.

    ERas enhances resistance to CPT-11 in gastric cancer.

    Kubota E, Kataoka H, Tanaka M, Okamoto Y, Ebi M, Hirata Y, Murakami K, Mizoshita T, Shimura T, Mori Y, Tanida S, Kamiya T, Aoyama M, Asai K, Joh T.

    Anticancer Res. 2011 Oct;31(10):3353-60.

    PMID:
    21965746
    [PubMed - indexed for MEDLINE]
    15.

    Effects of acute and chronic hypoxia on the radiosensitivity of gastric and esophageal cancer cells.

    Kato Y, Yashiro M, Fuyuhiro Y, Kashiwagi S, Matsuoka J, Hirakawa T, Noda S, Aomatsu N, Hasegawa T, Matsuzaki T, Sawada T, Ohira M, Hirakawa K.

    Anticancer Res. 2011 Oct;31(10):3369-75.

    PMID:
    21965748
    [PubMed - indexed for MEDLINE]
    16.

    Feasibility study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 for advanced gastric cancer.

    Fujitani K, Hasegawa H, Hirao M, Kurokawa Y, Tsujinaka T.

    Anticancer Res. 2011 Sep;31(9):3085-91.

    PMID:
    21868564
    [PubMed - indexed for MEDLINE]
    17.

    Phase I study of neoadjuvant chemoradiotherapy consisting of S-1 and cisplatin for patients with resectable advanced gastric cancer (KOGC-01).

    Takahashi T, Saikawa Y, Takaishi H, Takeuchi H, Wada N, Oyama T, Fukuda K, Fukada J, Kawaguchi O, Shigematsu N, Kitagawa Y.

    Anticancer Res. 2011 Sep;31(9):3079-83.

    PMID:
    21868563
    [PubMed - indexed for MEDLINE]
    18.

    Induction of cytotoxic T lymphocytes by CEA peptide-pulsed γδ T-cells isolated from patients with advanced cancer.

    Yamasaki A, Onishi H, Morisaki T, Katano M.

    Anticancer Res. 2011 Jul;31(7):2419-24.

    PMID:
    21873153
    [PubMed - indexed for MEDLINE]
    19.

    Comparison of staging between the old (6th edition) and new (7th edition) TNM classifications in advanced gastric cancer.

    Kikuchi S, Futawatari N, Sakuramoto S, Katada N, Yamashita K, Shibata T, Nemoto M, Watanabe M.

    Anticancer Res. 2011 Jun;31(6):2361-5.

    PMID:
    21737665
    [PubMed - indexed for MEDLINE]
    20.

    Docetaxel, cisplatin and 5-fluorouracil plus granulocyte colony-stimulating factor prophylaxis in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: experience at the Medical University of Vienna.

    Bojic M, Pluschnig U, Zacherl J, Thallinger CM, Ba-Ssalamah A, Maresch J, Datler P, Schoppmann SF, Hejna M.

    Anticancer Res. 2011 Jun;31(6):2379-82.

    PMID:
    21737668
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk